Skip to main content
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation

Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now.

Int J Biol Sci. 2021; 17(6): 1581–1587.
Published online 2021 Apr 10. doi: 10.7150/ijbs.58855
PMCID: PMC8071762
PMID: 33907522

Artificial intelligence in the diagnosis of COVID-19: challenges and perspectives

Shigao Huang,1,# Jie Yang,2,3,# Simon Fong,2, and Qi Zhao1,

Abstract

Artificial intelligence (AI) is being used to aid in various aspects of the COVID-19 crisis, including epidemiology, molecular research and drug development, medical diagnosis and treatment, and socioeconomics. The association of AI and COVID-19 can accelerate to rapidly diagnose positive patients. To learn the dynamics of a pandemic with relevance to AI, we search the literature using the different academic databases (PubMed, PubMed Central, Scopus, Google Scholar) and preprint servers (bioRxiv, medRxiv, arXiv). In the present review, we address the clinical applications of machine learning and deep learning, including clinical characteristics, electronic medical records, medical images (CT, X-ray, ultrasound images, etc.) in the COVID-19 diagnosis. The current challenges and future perspectives provided in this review can be used to direct an ideal deployment of AI technology in a pandemic.

Keywords: Artificial intelligence, COVID-19, diagnosis, deep learning, machine learning

Introduction

Coronavirus disease 2019 (COVID-19) was firstly reported in December 2019 1-3. It has caused a large number of deaths and negatively impacted people's lives worldwide, with more than 100 million confirmed cases of the new coronavirus (SARS-Cov-2) and more than 200 million cumulative deaths worldwide as of late January 20214, 5. The patients experience flu-like symptoms such as fever, dry cough, tiredness, difficulty breathing. In more severe cases, the SARS-CoV-2 infection often causes fatal pneumonia in the patients 6. Although the rapid progress in vaccines, the epidemic continues to spread out more than 200 countries and regions. In some countries, people have to face new lifestyles to combat COVID-19 7. Therefore, there is still an imminent need to develop antiviral drugs and medical practices to cure COVID-19 patients 5. Many researchers from all over the world are seeking the effective techniques to cope with such challenges 8, 9.

In severe infectious disease outbreaks, both hospitals and physicians are suffered with the increasing workloads that weaken their ability to classify and hospitalize the suspected patients. The previous reports indicated that some of patients with early coronaviral infection were negative for CT 10, limiting the ability of radiologists to reliably rule out disease. While waiting 4-48 hours for confirmation of SARS-CoV-2 coronavirus by RT-PCR, the infected patients may transmit the virus to the close contacts if insufficient resources are used to separate positive patients with other suspected cases. In one report, the hospital-acquired infection was inferred in approximately 40% of cases 11. It is imperative to speedily confirm patients for COVID-19 because initial false negative cases may increase the risk of transmission of the virus to others.

Artificial intelligence (AI) has been deployed at various levels of the health care system, including diagnosis, public health, clinical decision making, and therapeutics 12, 13. Particularly, AI algorithm plays an important role in the fast detection of COVID-19 patients during the current pandemic 14. The number of studies using AI techniques to diagnose COVID-19 rapidly increased in 2020. Most reviews focus on describing diagnosis of COVID-19 from chest CT images using AI technology 15. Therefore, we will comprehensively review the applications of AI for rapid diagnosis of COVID-19 with different medical analyses as well as discuss their challenges and perspectives in COVID-19. As shown in Fig. Fig.11, it is mainly compiled from two aspects: machine learning (ML) and deep learning (DL), including electronic medical records, and medical images (CT, X-ray, ultrasound images, etc.), in clinical COVID-19 diagnosis.

An external file that holds a picture, illustration, etc.
Object name is ijbsv17p1581g001.jpg

A flowchart of the artificial intelligence methods for COVID-19 diagnosis: machine learning and deep learning were applied in the medical characteristic to diagnosis the COVID-19 infection.

Machine learning-based diagnostic applications

The potential applications of ML for COVID-19 have been previously described 14, 16-26. The details are summarized in Table Table11.

Table 1

Application of machine learning-based COVID-19 diagnosis

AuthorsCountriesData SourcesNo. of PatientsTechniquesPerformances
An et al.5KoreaKNHIS10237LASSO, LSVM, SVM with radial basis function kernel, RF, KNNSensitivities (90.7% [95% confidence interval: 83.3, 97.3] and 92.0% [85.9, 98.1], respectively) Specificities (91.4% [90.3, 92.5] and 91.8%, [90.7, 92.9], respectively) AUC (0.963 [0.946, 0.979] and 0.962 [0.945, 0.979], respectively)
Zoabi et al.20IsraelIsraeli Ministry of Health8393Gradient boosting with decision tree0.90 auROC 95% CI: 0.892-0.905
Batista et al.23BrazilBrazilian Ministry of Health235Neural networks,RF,LR,SVM,Gradient boosting treesAUC: 0.85; Sensitivity: 0.68; Specificity: 0.85; Brier Score: 0.16
Prefeitura et al.24BrazilPublic Health Department
of Florianópolis
3916Random forestAccuracy:0.66 (UI 95%0.62-0.69)Sensitivity:0.65 (UI 95%0.57-0.75);Specificity:0.66 (UI 95%0.60-0.70)
Mei et al.14China18 medical centers
in 13 provinces in China
419CNN, SVM, RF, MLPAUC 0.92
Chen et al.19ChinaUnion Hospital, Wuhan, China214RFAccuracy>95%
Li et al.16USAPublic data413XGBoostSensitivity 92.5%;Specificity 97.9%
Avila et al.25BrazilHospital Israelita Albert Einstein
(HIAE - São Paulo, Brazil)
510Naïve Bayes ClassifierSensitivity and Specificity 76.7%

*Public data:https://github.com/yoshihiko1218/COVID19ML, KNHIS: Korean National Health Insurance Service, SVM: Support Vector Machines, LSVM: Linear support vector machine,NB: Naïve Bayes, RF: Random Forest, LR: Logistic Regression, KNN: K-nearest neighbors, ET: Extremely Randomized Trees, DT: Decision Tree, CNN: Convolutional Neural Networks, MLP: Multi-layer perceptron, LASSO: Least absolute shrinkage and selection operator, AUROC: Area under the receiver operating characteristic curve, AUC: Area under the curve

The first priority of ML was suggested as technical support for early detection and diagnosis of infections. A recent study demonstrated that the more accurate diagnosis could be generated using a computational model trained on large clinical datasets 16. An association between males and higher serum lymphocyte and neutrophil levels was identified by applying ML to reanalyze COVID-19 data from 151 published studies. The COVID-19 patients could be classified into three clinically relevant subtypes based on serum levels of immune cells, gender, and reported symptoms. A sensitivity of 92.5% and a specificity of 97.9% were achieved to discriminate COVID-19 patients from influenza patients using a computational classification model. another study reported that early identification could be performed by a ML model based on the clinical symptoms without CT images at the time of fever clinic admission 17. Peng M et al reported that 18 diagnostic indicators for COVID-19 were highly associated with a significant diagnosis of COVID-19 using AI screening, which improved the accuracy of the clinical diagnosis 18. Chen et al described a ML random forest model used to classify COVID-19 clinical types, which achieved >90% predictive accuracy 19. Zoabi et al generated a ML model that trained on data from 51831 tested individuals in Israel. This model resulted in high accuracy using only eight binary features 20. A combination of seven ML algorithm based on data from UCLA Health System in United States was established to diagnose COVID-19 in the inpatient setting 21. In the test set (n=392), the combined model achieved excellent diagnostic metrics compared to RT-PCR. An et al developed five ML algorithms for death prediction in a case dataset that was provided by the Korean National Health Insurance Service (KNHIS) 5. In prediction of mortality, the sensitivity and specificity exceeded 90% while the areas under the curves (AUC) exceeded 96%.

Chest CT has been used to evaluate the patients with suspected SARS-CoV-2 infection. AI system had equal sensitivity as compared to a senior thoracic radiologist. The radiologists with less expertise in chest imaging demand AI-assisted screening. In a test set of 279 patients, an AI algorithm combining chest CT presentation correctly identified 68%, while radiologists classified all of these patients as COVID-19 negative 14.

Developed ML models are suitable for surveillance efforts to predict the SARS-CoV-2 infection risk of patients with severe diseases. Monahan et al reported that two unique ML models were generated to predict the risk of the hemodialysis (HD) patients having the undetected SARS-CoV-2 infections 27. Through analyzing more than ten thousand patients, they identified top predictor of an HD patient having a SARS-CoV-2 infection in the prior week.

Deep learning-based diagnostic applications

DL, as a subset of ML, has been explored extensively in the diagnosis of COVID-19, especially in the field of lung detection images, including CT images, X-ray images and ultrasound images. The details are summarized in Table Table22.

Table 2

Application of deep learning-based COVID-19 diagnosis

AuthorsData SourcesNo. of ImagesType of ImagesNo. of ClassesTechniquesType of modelPerformances
Ardakani et al.29Real-time data fromuniversity hospital1020 (COVID19=510,non-COVID19=510)CT2 (COVID-19,non-COVID19)AlexNet, VGG16, VGG-19,SqueezeNet, GoogleNet, MobileNet-V2, ResNet-18, ResNet-50, ResNet-101, XceptionPre-trained modelAccuracy=99.51, Sensitivity=100, Specificity=99.02, Precision=99.27, AUC=99.4, NPV=100
Wu et al. 28China Medical University, Beijing Youan Hospital495 (COVID19=368, otherpneumonia=127)CT2 (COVID-19, other pneumonia)ResNet50Pre-trained modelAccuracy=76, Sensitivity=81.1, Specificity=61.5, AUC=81.9
Cifci 30kaggle.com (benchmarkweb of dataset science)5800CT2 (COVID-19, other pneumonia)AlexNet, Inception-V4Pre-trained modelAccuracy=94.74, Sensitivity=87.37, Specificity=87.45
Apostolopoulosand Bessiana33COVID-19 X-ray imagedatabase48, Kaggledataset*,1442 (COVID19=224,pneumonia=714,normal=504)X-RAY3 (COVID-19, pneumonia, normal)VGG19, MobileNetv2, Inception, Xception, InceptionResNetv2Pre-trained modelAccuracy=96.78, Sensitivity=98.66, Specificity=96.46
Loey et al. 34COVID-19 X-ray imagedatabase48, Dataset*307(COVID=69, normal=79,pneumonia_bac=79,pneumonia_vir=79)X-RAY4 (COVID, normal, pneumonia_ba, pneumonia_vir)GAN, Alexnet, Googlenet, Resnet18Pre-trained modelAccuracy=85.2, Precision= 80.6,
Hasan et al.31COVID-19 Dataset*, SPIEAAPM-NCI Lung NoduleClassification Challenge Dataset321 (COVID19=118,pneumonia=96,healthy=107)CT3 (COVID19, pneumonia, healthy)QDE-DFCustomized ModelAccuracy=99.68
Amyar et al.32COVID-CT49, COVID-19 CTsegmentation dataset*,a hospital named Henri Becquerel Center1044 (COVID19=449, nonCOVID-19=595)CT2 (COVID19, nonCOVID-19)EncoderDecoder withmulti-layerperceptronCustomized ModelAccuracy=86, Sensitivity=94, Specificity=79, AUC=93
Ozturk etal.36COVID-19 X-ray image database 48, ChestX-ray8 501127 (COVID=127,no-finding=500,pneumonia=500)X-RAY3 (COVID, nofinding,pneumonia)DarkNetCustomized ModelAccuracy=98.08, Sensitivity=95.13, Specificity=95.3, Precision=98.03, F1-Score=96.51
Rahimzadeh and Attar35COVID-19 X-ray image database 48, RSNA Pneumonia Detection Challenge dataset 5115085 (COVID19=180, pneumonia=6054, normal= 8851)X-RAY3 (COVID-19, pneumonia, normal)ConcatenatedCNNCustomized ModelAccuracy=99.50, Sensitivity=80.53, Specificity=99.56

*Kaggle dataset: https://www.kaggle.com/andrewmvd/convid19-x-rays,

Dataset: https://drive.google.com/uc?id=1coM7x3378fOu2l6Pg2wldaOI7Dntu1a,

Covid-19 Dataset: https://radiopaedia.org,

Archive, C.I. SPIE-AAPM-NCI Lung Nodule Classification Challenge Dataset: https://www.cancerimagingarchive.net,

COVID-19 CT segmentation dataset: http://medicalsegmentation.com/covid19/ .Note: CT: computerized tomography; CNN: Convolutional Neural Network

Wu et al developed a DL-based screening framework for coronavirus through a multi-view chest CT imaging 28. The framework trained on multi-view images of chest CT images from two different hospitals in China through a Convolutional Neural Network (CNN) variant, ResNet 50, with a total dataset of 495 patient images, including 368 confirmed cases and 127 images of suspected pneumonia cases. Based on DL method, the proposed diagnosis model showed 76% accuracy, 81.1% sensitivity, 61.5% specificity, and 81.9% AUC. Ardakani et al developed a variant system based on CT images in combination with the CNN architectures for COVID-19 diagnostic detection in which ten convolutional neural networks were used to discriminate positive COVID-19 infections from non-infection groups. Among all networks, ResNet-101 showed the best performance with 99.51% accuracy, 100% sensitivity, 99.4% AUC, and 99.02% specificity 29. Cifci et al diagnosed infections from CT images used AlexNet and Inception-V4, pre-trained models that are widely used in medical image analysis 30. The dataset consists of a public database of 5800 CT images (4640 CT images, with 4640 training samples and 1160 test sets). The dataset analysis has shown a sensitivity of 94.74% and a specificity of 87.37%.

Hybrid systems show the higher accuracy than a single model. Hasan et al generated a hybrid system that combined Q-deformed entropy and DL features (QDE-DF) with LSTM from extracting deep features of CT images 31. The dataset contains 321 chest CT samples, including 118 of COVID-19 cases images, 96 images of pneumonia cases, and 107 images of healthy individuals. As the result, 16 core attributes were extracted by the proposed composite model. The analysis achieved 99.68% accuracy in the training and test sets in the ratio of 7:3.

Multitask DL based model can be used to detect COVID-19 lesions on CT scans. A multitask DL model, including segmentation, classification and reconstruction, was used to detect COVID-19 patient and segment COVID-19 lesion from chest CT images 32. The proposed model was used to analyze a dataset of 1369 patients including 449 patients with COVID-19, 425 healthy individuals, 98 with lung cancer and 397 cases of other diseases. The model had an accuracy of 86%, a sensitivity of 94%, a specificity of 79%, and an AUC of 93%.

Moreover, transfer learning has been applied for the early diagnosis of coronaviruses based on X-ray imaging. Apostolopoulos and Bessiana proposed a system for the automatic diagnosis of COVID-19 cases in which five CNN variants (VGG19, MobileNetv2, Inception, Xception, and Inception-ResNetv2) were used to analyze a dataset of X-ray images from patients with common bacterial pneumonia, confirmed Covid-19 disease, and normal incidents 33. The dataset analysis suggests that DL with X-ray imaging has a high accuracy, sensitivity, and specificity (96.78%, 98.66%, and 96.46%, respectively). A generative adversarial network (GAN) with deep transfer learning has been proposed for coronavirus detection in chest X-ray images 34. The total number of X-ray images in the collection was 307 and contained four categories: COVID-19, normal, pneumonia bacteria, and pneumonia virus. The models contain the Alexnet, Googlenet, and Restnet18. The accuracy of selecting Alexnet as the primary deep transfer model can reach 80.6% when four categories are included, while the accuracy of selecting Googlenet as the primary model can reach 85.2% when three classes are included. Another COVID-19 diagnosis-Net based on an X-ray image was proposed by Ucar and Korkmaz 35. Image data from three public datasets obtained 98.26% accuracy, 98.25% specificity, and 97.39% F1-score in the proposed system. In another study, a DarkNet model for automatic COVID-19 detection using chest X-ray images has been developed 36. The DarkNet model is a classifier used as a "you only look-once" (YOLO) real-time object detection system. The proposed model was evaluated for binary classification (COVID vs. No-Findings, the classification accuracy of 98.08%) and multi-class classification (COVID vs. No-Findings vs. Pneumonia. It has shown a classification accuracy of 98.08%. In addition, the generated heatmaps can assist the clinicians to locate the affected regions on chest X-rays.

Lung Ultrasonography (LUS) has been used for the detection and management of acute respiratory disorders. A recent study shows that DL techniques may assist clinician for the analysis of LUS images from COVID-19 patients 37. A model with three different tasks on LUS imaging: frame-based classification, video-level grading and pathological artifact segmentation, was proposed in the diagnosis of COVID-19. It demonstrated accurate prediction and localization of LUS imaging biomarkers in COVID-19 patients.

Challenges and perspectives

AI has great potential and opportunity for rapid analysis of large amounts of data. It has played an important role in the prevention of COVID-19 outbreak 38. AI models may be as accurate as experienced radiologists to diagnose COVID-19 38.

It is noteworthy that although some patients infected with COVID-19 are asymptomatic, they have the potential to become transmitters of the virus 6, 39. Although the infection can be confirmed by a polymerase chain reaction, COVID-19 patients with pneumonia symptoms may show a pattern on chest X-ray or CT images that are only moderately characteristic for the clinicians 40. It is difficult to find people who are currently infected with COVID-19 but are asymptomatic 41. The transmission rate of COVID-19 is determined with the ability to confidently recognize infected patients with low false-negative rates. Meanwhile, an effective control of false positives can avoid unnecessary quarantine of patients and thus further reduce the burden on the health care system.

Biomedical imaging (chest X-ray, CT scan, and ultrasound images, etc.) enables to visualize symptoms of pneumonia. Image processing techniques are attractive in the areas of biomedicine and cancer diagnosis 42. It is well known that AI-based biomedical image diagnosis has achieved remarkable success. ML and DL methods have become valuable tools for the discovery of various diseases 40, 43-45. For example, although some patients have already infected by SARS-Cov-2, they show the normal chest CT images. Therefore, the negative predictive value of chest CT images is limited and does not completely rule out infection. The accuracy of the solo AI diagnosis is still challenged. Therefore, to meet clinical needs, AI algorithms is required to combine chest imaging with clinical symptoms, exposure history, and laboratory tests in the diagnosis of COVID-19.

False negative rate is usually high with the laboratory tests, such as nucleotide RT-PCT 46. Medical image screening can provide an intuitive and accurate diagnosis when it is used as the assisted testing method for COVID-19 47. In some epidemic countries, such China and United States, the AI model to diagnose negative sensitivity with CT has been used in the early infections 38. This new strategy provides spare capacity for CT and X-ray imaging scans with the advantages of rapid COVID-19 diagnosis.

Conclusion

AI model may be as accurate as experienced physicians at diagnosing COVID-19. In this review, we discuss the challenges and perspectives of ML and DL in the COVID-19 as well as the need for further research. The clinical application of AI in the diagnosis of COVID-19 is promising, and additional extensive research is required.

Table 3

Challenges and perspectives of machine learning-based COVID-19 diagnosis

ChallengesPerspectives
Improve the accuracy of the AI diagnosisCombine chest imaging with clinical symptoms, exposure history, and laboratory tests in the diagnosis of COVID-19
Reduce the false negative diagnosis rateProvides spare capacity for CT and X-ray imaging scans with the advantages of rapid COVID-19 diagnosis.

Acknowledgments

The study is supported by the Science and Technology Development Fund, Macau SAR (File no. FDCT/0015/2018/A1, FDCT/126/2014/A3), the National Key R&D Program of China (2019YFA0904400), the Multi-Year Research Grant of University of Macau (File no. MYRG2019-00069-FHS, MYRG2016-00069-FST), Guangzhou Science and Technology Innovation and Development of Special Funds (201807010004, EF003/FST-FSJ/2019/GSTIC, and EF004/FST-FSJ/2019/GSTI), National Natural Science Foundation of China (31440041), the Project of the Science and Technology Research Program of Chongqing Municipal Education Commission of China (File no. KJQN202003601, KJZD-K201903601).

Author Contributions

SH and JY contributed equally to this paper. SH, JY, SF, and QZ conceived the paper. SH and JY wrote the initial draft and edits. All authors approved the final draft of the manuscript. QZ and SF are the supervisors. The corresponding authors are responsible that all listed authors meet authorship criteria.

References

1. Zhou G, Zhao Q. Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2. Int J Biol Sci. 2020;16:1718–23. [PMC free article] [PubMed] [Google Scholar]
2. Yi Y, Lagniton PNP, Ye S, Li E, Xu RH. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci. 2020;16:1753–66. [PMC free article] [PubMed] [Google Scholar]
3. Deng CX. The global battle against SARS-CoV-2 and COVID-19. Int J Biol Sci. 2020;16:1676–7. [PMC free article] [PubMed] [Google Scholar]
4. Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A. et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) International journal of surgery. 2020;76:71–6. [PMC free article] [PubMed] [Google Scholar]
5. Organization WH. Coronavirus disease 2019 (COVID-19): situation report, 82. 2020.
6. Huff HV, Singh A. Asymptomatic transmission during the coronavirus disease 2019 pandemic and implications for public health strategies. Clinical Infectious Diseases. 2020;71:2752–6. [PMC free article] [PubMed] [Google Scholar]
7. Bhattacharya S, Maddikunta PKR, Pham Q-V, Gadekallu TR, Chowdhary CL, Alazab M. et al. Deep learning and medical image processing for coronavirus (COVID-19) pandemic: A survey. Sustainable cities and society. 2020;65:102589. [PMC free article] [PubMed] [Google Scholar]
8. Fanelli D, Piazza F. Analysis and forecast of COVID-19 spreading in China, Italy and France. Chaos, Solitons & Fractals. 2020;134:109761. [PMC free article] [PubMed] [Google Scholar]
9. Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S. et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. The lancet infectious diseases. 2020;20:553–8. [PMC free article] [PubMed] [Google Scholar]
10. Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X. et al. CT imaging features of 2019 novel coronavirus (2019-nCoV) Radiology. 2020;295:202–7. [PMC free article] [PubMed] [Google Scholar]
11. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. Journal of medical virology. 2020;92:568–76. [PMC free article] [PubMed] [Google Scholar]
12. Chen J, See KC. Artificial Intelligence for COVID-19: Rapid Review. J Med Internet Res. 2020;22:e21476. [PMC free article] [PubMed] [Google Scholar]
13. Vaishya R, Javaid M, Khan IH, Haleem A. Artificial Intelligence (AI) applications for COVID-19 pandemic. Diabetes Metab Syndr. 2020;14:337–9. [PMC free article] [PubMed] [Google Scholar]
14. Mei X, Lee H-C, Diao K-y, Huang M, Lin B, Liu C. et al. Artificial intelligence-enabled rapid diagnosis of patients with COVID-19. Nature medicine. 2020;26:1224–8. [PMC free article] [PubMed] [Google Scholar]
15. Ozsahin I, Sekeroglu B, Musa MS, Mustapha MT, Uzun Ozsahin D. Review on Diagnosis of COVID-19 from Chest CT Images Using Artificial Intelligence. Comput Math Methods Med. 2020;2020:9756518. [PMC free article] [PubMed] [Google Scholar]
16. Li WT, Ma J, Shende N, Castaneda G, Chakladar J, Tsai JC. et al. Using machine learning of clinical data to diagnose COVID-19: a systematic review and meta-analysis. BMC medical informatics and decision making. 2020;20:1–13. [PMC free article] [PubMed] [Google Scholar]
17. Feng C, Huang Z, Wang L, Chen X, Zhai Y, Zhu F, A novel triage tool of artificial intelligence assisted diagnosis aid system for suspected COVID-19 pneumonia in fever clinics. 2020. [PMC free article] [PubMed]
18. Peng M, Yang J, Shi Q, Ying L, Zhu H, Zhu G, Artificial intelligence application in COVID-19 diagnosis and prediction. 2020.
19. Chen Y, Ouyang L, Bao FS, Li Q, Han L, Zhu B, An interpretable machine learning framework for accurate severe vs non-severe covid-19 clinical type classification. Available at SSRN 3638427. 2020.
20. Zoabi Y, Deri-Rozov S, Shomron N. Machine learning-based prediction of COVID-19 diagnosis based on symptoms. npj Digital Medicine. 4: 1-5. [PMC free article] [PubMed]
21. Goodman-Meza D, Rudas A, Chiang JN, Adamson PC, Ebinger J, Sun N. et al. A machine learning algorithm to increase COVID-19 inpatient diagnostic capacity. Plos one. 2020;15:e0239474. [PMC free article] [PubMed] [Google Scholar]
22. Hasan AM, Al-Jawad MM, Jalab HA, Shaiba H, Ibrahim RW, AL-Shamasneh AaR. Classification of covid-19 coronavirus, pneumonia and healthy lungs in ct scans using q-deformed entropy and deep learning features. Entropy. 2020;22:517. [PMC free article] [PubMed] [Google Scholar]
23. de Moraes Batista AF, Miraglia JL, Donato THR, Chiavegatto Filho ADP. COVID-19 diagnosis prediction in emergency care patients: a machine learning approach. medRxiv. 2020.
24. Garcia LP, Goncalves AV, de Andrade MP, Pedebos LA, Vidor AC, Zaina R, Estimating underdiagnosis of covid-19 with nowcasting and machine learning: Experience from brazil. medRxiv. 2020. [PubMed]
25. Avila E, Kahmann A, Alho C, Dorn M. Hemogram data as a tool for decision-making in COVID-19 management: applications to resource scarcity scenarios. PeerJ. 2020;8:e9482. [PMC free article] [PubMed] [Google Scholar]
26. Brinati D, Campagner A, Ferrari D, Locatelli M, Banfi G, Cabitza F. Detection of COVID-19 infection from routine blood exams with machine learning: a feasibility study. Journal of medical systems. 2020;44:1–12. [PMC free article] [PubMed] [Google Scholar]
27. Monaghan C, Larkin JW, Chaudhuri S, Han H, Jiao Y, Bermudez KM, Artificial intelligence for covid-19 risk classification in kidney disease: Can technology unmask an unseen disease? medRxiv. 2020.
28. Wu X, Hui H, Niu M, Li L, Wang L, He B. et al. Deep learning-based multi-view fusion model for screening 2019 novel coronavirus pneumonia: a multicentre study. European Journal of Radiology. 2020;128:109041. [PMC free article] [PubMed] [Google Scholar]
29. Ardakani AA, Kanafi AR, Acharya UR, Khadem N, Mohammadi A. Application of deep learning technique to manage COVID-19 in routine clinical practice using CT images: Results of 10 convolutional neural networks. Computers in Biology and Medicine. 2020;121:103795. [PMC free article] [PubMed] [Google Scholar]
30. Cifci MA. Deep learning model for diagnosis of corona virus disease from CT images. Int J Sci Eng Res. 2020;11:273–8. [Google Scholar]
31. Hasan AM, Al-Jawad MM, Jalab HA, Shaiba H, Ibrahim RW, Al-Shamasneh AR. Classification of Covid-19 Coronavirus, Pneumonia and Healthy Lungs in CT Scans Using Q-Deformed Entropy and Deep Learning Features. Entropy (Basel) 2020. 22. [PMC free article] [PubMed]
32. Amyar A, Modzelewski R, Li H, Ruan S. Multi-task deep learning based CT imaging analysis for COVID-19 pneumonia: Classification and segmentation. Computers in Biology and Medicine. 2020;126:104037. [PMC free article] [PubMed] [Google Scholar]
33. Apostolopoulos ID, Mpesiana TA. Covid-19: automatic detection from x-ray images utilizing transfer learning with convolutional neural networks. Physical and Engineering Sciences in Medicine. 2020;43:635–40. [PMC free article] [PubMed] [Google Scholar]
34. Loey M, Smarandache F, M Khalifa NE. Within the lack of chest COVID-19 X-ray dataset: a novel detection model based on GAN and deep transfer learning. Symmetry. 2020;12:651. [Google Scholar]
35. Rahimzadeh M, Attar A. A modified deep convolutional neural network for detecting COVID-19 and pneumonia from chest X-ray images based on the concatenation of Xception and ResNet50V2. Informatics in Medicine Unlocked. 2020;19:100360. [PMC free article] [PubMed] [Google Scholar]
36. Ozturk T, Talo M, Yildirim EA, Baloglu UB, Yildirim O, Acharya UR. Automated detection of COVID-19 cases using deep neural networks with X-ray images. Computers in biology and medicine. 2020;121:103792. [PMC free article] [PubMed] [Google Scholar]
37. Roy S, Menapace W, Oei S, Luijten B, Fini E, Saltori C. et al. Deep learning for classification and localization of COVID-19 markers in point-of-care lung ultrasound. IEEE Transactions on Medical Imaging. 2020;39:2676–87. [PubMed] [Google Scholar]
38. Mei X, Lee H-C, Diao K-y, Huang M, Lin B, Liu C. et al. Artificial intelligence-enabled rapid diagnosis of patients with COVID-19. Nature Medicine. 2020;26:1224–8. [PMC free article] [PubMed] [Google Scholar]
39. Day M. Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village. BMJ: British Medical Journal (Online) 2020. 368. [PubMed]
40. Huang S, Yang J, Fong S, Zhao Q. Artificial intelligence in cancer diagnosis and prognosis: Opportunities and challenges. Cancer Letters. 2020;471:61–71. [PubMed] [Google Scholar]
41. Bastolla U. How lethal is the novel coronavirus, and how many undetected cases there are? The importance of being tested. medRxiv. 2020.
42. Khan FA, Asif M, Ahmad A, Alharbi M, Aljuaid H. Blockchain technology, improvement suggestions, security challenges on smart grid and its application in healthcare for sustainable development. Sustainable Cities and Society. 2020;55:102018. [Google Scholar]
43. Yang J, Huang S, Tang R, Hu Q, Lan K, Wang H, Broad Learning with Attribute Selection for Rheumatoid Arthritis. 2020 IEEE International Conference on Systems, Man, and Cybernetics (SMC): IEEE. 2020. p. 552-8.
44. Huang S, Yang J, Fong S, Zhao Q. Mining Prognosis Index of Brain Metastases Using Artificial Intelligence. Cancers. 2019;11:1140. [PMC free article] [PubMed] [Google Scholar]
45. Peng M, Huang S, Lv Q, Chen C, Qin J, He M, Distribution of ABO Blood Groups and Their Association With Low Risk of Severe COVID-19 Infection in Patients. Research Square. 2021. DOI: 10.21203/rs.3.rs-139563/v1.
46. Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S. et al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. Journal of Medical Virology. 2020;92:1518–24. [PMC free article] [PubMed] [Google Scholar]
47. Giri B, Pandey S, Shrestha R, Pokharel K, Ligler FS, Neupane BB. Review of analytical performance of COVID-19 detection methods. Analytical and Bioanalytical Chemistry. 2021;413:35–48. [PMC free article] [PubMed] [Google Scholar]
48. Cohen JP, Morrison P, Dao L, Roth K, Duong TQ, Ghassemi M. Covid-19 image data collection: Prospective predictions are the future. arXiv preprint arXiv:200611988. 2020.
49. Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J. Chest CT for typical coronavirus disease 2019 (COVID-19) pneumonia: relationship to negative RT-PCR testing. Radiology. 2020;296:E41–E5. [PMC free article] [PubMed] [Google Scholar]
50. Wang X, Peng Y, Lu L, Lu Z, Bagheri M, Summers RM. Chestx-ray8: Hospital-scale chest x-ray database and benchmarks on weakly-supervised classification and localization of common thorax diseases. Proceedings of the IEEE conference on computer vision and pattern recognition. 2017. p. 2097-106.
51. Abbas A, Abdelsamea MM, Gaber MM. Classification of COVID-19 in chest X-ray images using DeTraC deep convolutional neural network. Applied Intelligence. 2020. pp. 1–11. [PMC free article] [PubMed]

Articles from International Journal of Biological Sciences are provided here courtesy of Ivyspring International Publisher